Skip to main content
NVDA-0.20%AAPL+0.07%GOOGL-1.17%MSFT-0.04%AMZN-0.03%TSM+2.85%SPCX-1.20%AVGO+0.21%META-0.28%TSLA-0.32%SKHY+8.14%MU-0.27%BRK-B-0.41%LLY-0.98%JPM-0.94%WMT-1.18%AMD+4.69%V-0.97%JNJ-1.15%XOM-1.70%ASMLa+3.40%0700.HK+2.26%MA-1.11%INTC+4.51%1398.HK+1.99%ORCL+3.11%ABBV-1.49%BAC-0.57%CSCO+0.54%CVX-1.32%COST-1.04%LRCX+5.12%KO-0.83%CAT+1.72%0005.HK+1.96%HSBA.L+1.06%AMAT+4.31%UNH-0.95%AP2d+4.21%GE+1.09%PG-0.33%DELL+1.47%MS+0.25%3988.HK+2.02%1816.HK-0.68%NFLX-5.35%HD+0.94%0857.HK+1.40%GS+0.07%NVS-1.90%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPZAR0.00%AUDNZD0.00%AUDSGD0.00%AUDUSD0.00%CHFNOK0.00%EURPLN0.00%PLNJPY0.00%NZDCAD0.00%NZDMXN0.00%CHFJPY0.00%CADCHF0.00%EURUSD0.00%EURJPY0.00%AUDCAD0.00%GBPCAD0.00%GBPAUD0.00%EURCAD0.00%EURNZD0.00%EURNOK0.00%EURHKD0.00%EURCHF0.00%NZDSGD0.00%NZDCHF0.00%EURCZK0.00%SGDJPY0.00%NOKJPY0.00%NZDUSD0.00%EURGBP0.00%GBPJPY0.00%USDCAD0.00%USDCHF0.00%USDCNH0.00%USDHKD0.00%USDJPY0.00%USDMXN0.00%USDNOK0.00%USDSEK0.00%USDTHB0.00%USDTRY0.00%USDZAR0.00%CADJPY0.00%AUDNOK0.00%EURAUD0.00%EURCNH0.00%EURSGD0.00%EURZAR0.00%USDDKK0.00%GBPCHF0.00%GBPUSD0.00%AUDDKK0.00%CHFSGD0.00%AUDJPY0.00%CHFSEK0.00%AUDCHF0.00%USDSGD0.00%USDPLN0.00%NZDJPY0.00%EURDKK0.00%EURSEK0.00%GBPNZD0.00%GBPSGD0.00%GAGUSD0.00%C10.00%HG10.00%S10.00%USOIL0.00%W10.00%XAGUSD0.00%XAUUSD0.00%XNGUSD0.00%COCOA0.00%COFFEE0.00%COTTON0.00%BTCUSD-2.00%BTCUSDT+4.84%ETHUSD-2.25%USDTUSD0.00%BNBUSDT+14.21%XRPUSD-3.87%SOLUSD-2.14%TRXUSDT+0.28%ZECUSDT+7.52%DOGEUSD-3.75%XMRUSDT-0.44%ADAUSDT-15.85%LINKUSD-1.91%XLMUSD-3.05%XLMUSDT+2.90%BCHUSDT-2.92%AVAXUSDT-21.55%LTCUSD-1.51%UNIUSD-3.35%SUIUSDT-20.75%TONUSD+25.16%HBARUSDT-2.04%TONUSDT+27.64%SUIUSD-4.04%TAOUSDT-1.51%UNIUSDT+88.10%AAVEUSD-2.41%NEARUSDT+55.89%PEPEUSD+10008521.15%DOTUSDT-2.25%ICPUSDT-2.40%ETCUSDT-12.54%ONDOUSDT-2.37%WLDUSDT-3.78%ARBUSDT-8.21%ATOMUSDT-1.29%JUPUSDT-6.05%PENGUUSDT+95663.60%STXUSDT-4.51%INJUSDT-4.83%FETUSDT-2.40%PYTHUSDT-2.14%SEIUSDT-5.66%TIAUSDT-5.21%IMXUSDT-1.66%WIFUSDT-6.06%OPUSDT-4.63%GRTUSDT-2.97%NVDA-0.20%AAPL+0.07%GOOGL-1.17%MSFT-0.04%AMZN-0.03%TSM+2.85%SPCX-1.20%AVGO+0.21%META-0.28%TSLA-0.32%SKHY+8.14%MU-0.27%BRK-B-0.41%LLY-0.98%JPM-0.94%WMT-1.18%AMD+4.69%V-0.97%JNJ-1.15%XOM-1.70%ASMLa+3.40%0700.HK+2.26%MA-1.11%INTC+4.51%1398.HK+1.99%ORCL+3.11%ABBV-1.49%BAC-0.57%CSCO+0.54%CVX-1.32%COST-1.04%LRCX+5.12%KO-0.83%CAT+1.72%0005.HK+1.96%HSBA.L+1.06%AMAT+4.31%UNH-0.95%AP2d+4.21%GE+1.09%PG-0.33%DELL+1.47%MS+0.25%3988.HK+2.02%1816.HK-0.68%NFLX-5.35%HD+0.94%0857.HK+1.40%GS+0.07%NVS-1.90%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPZAR0.00%AUDNZD0.00%AUDSGD0.00%AUDUSD0.00%CHFNOK0.00%EURPLN0.00%PLNJPY0.00%NZDCAD0.00%NZDMXN0.00%CHFJPY0.00%CADCHF0.00%EURUSD0.00%EURJPY0.00%AUDCAD0.00%GBPCAD0.00%GBPAUD0.00%EURCAD0.00%EURNZD0.00%EURNOK0.00%EURHKD0.00%EURCHF0.00%NZDSGD0.00%NZDCHF0.00%EURCZK0.00%SGDJPY0.00%NOKJPY0.00%NZDUSD0.00%EURGBP0.00%GBPJPY0.00%USDCAD0.00%USDCHF0.00%USDCNH0.00%USDHKD0.00%USDJPY0.00%USDMXN0.00%USDNOK0.00%USDSEK0.00%USDTHB0.00%USDTRY0.00%USDZAR0.00%CADJPY0.00%AUDNOK0.00%EURAUD0.00%EURCNH0.00%EURSGD0.00%EURZAR0.00%USDDKK0.00%GBPCHF0.00%GBPUSD0.00%AUDDKK0.00%CHFSGD0.00%AUDJPY0.00%CHFSEK0.00%AUDCHF0.00%USDSGD0.00%USDPLN0.00%NZDJPY0.00%EURDKK0.00%EURSEK0.00%GBPNZD0.00%GBPSGD0.00%GAGUSD0.00%C10.00%HG10.00%S10.00%USOIL0.00%W10.00%XAGUSD0.00%XAUUSD0.00%XNGUSD0.00%COCOA0.00%COFFEE0.00%COTTON0.00%BTCUSD-2.00%BTCUSDT+4.84%ETHUSD-2.25%USDTUSD0.00%BNBUSDT+14.21%XRPUSD-3.87%SOLUSD-2.14%TRXUSDT+0.28%ZECUSDT+7.52%DOGEUSD-3.75%XMRUSDT-0.44%ADAUSDT-15.85%LINKUSD-1.91%XLMUSD-3.05%XLMUSDT+2.90%BCHUSDT-2.92%AVAXUSDT-21.55%LTCUSD-1.51%UNIUSD-3.35%SUIUSDT-20.75%TONUSD+25.16%HBARUSDT-2.04%TONUSDT+27.64%SUIUSD-4.04%TAOUSDT-1.51%UNIUSDT+88.10%AAVEUSD-2.41%NEARUSDT+55.89%PEPEUSD+10008521.15%DOTUSDT-2.25%ICPUSDT-2.40%ETCUSDT-12.54%ONDOUSDT-2.37%WLDUSDT-3.78%ARBUSDT-8.21%ATOMUSDT-1.29%JUPUSDT-6.05%PENGUUSDT+95663.60%STXUSDT-4.51%INJUSDT-4.83%FETUSDT-2.40%PYTHUSDT-2.14%SEIUSDT-5.66%TIAUSDT-5.21%IMXUSDT-1.66%WIFUSDT-6.06%OPUSDT-4.63%GRTUSDT-2.97%
GE

Geron Corporation (GERN)

NASDAQHealthcare

$1.57
+$0.06 (+4.0%)
Market closed

Last close at September 4, 2026 at 20:00 UTC

Day Range$1.46 - $1.59
Avg. Volume (3M)9.8M
Market Cap$1B
52 Week Range
$1.04$2.01
Next EarningsIn 61 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$57.4M100%
Gross Profitminus cost of goods$48.2M84%

In plain terms: out of every $100 in revenue, Geron Corporation currently loses $29.

Fundamentals & Financials

Revenue (TTM)
$204.5M
Net Income (TTM)
-$69.8M
EPS (TTM)
-$0.1
ROA (TTM)
-13.47%
Current Ratio
6.92

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

0.0%Q1 2026-$0.03
+66.7%Q2 2026-$0.01
-125.2%Q3 2026-$0.02
Next

Nov 4

in 61 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Geron Corporation

Geron Corporation is a NASDAQ-listed biotechnology company focused on imetelstat, a telomerase inhibitor for blood cancers. In FY2025, the company generated $183.9 million in revenue. Geron develops its therapy within the healthcare sector around a single oncology asset designed to target malignant cell biology.

Name
Geron Corporation
CEO
Harout Semerjian
Industry
Healthcare
Year Founded
1990
Employees
258

Today's Snapshot

AI-generated

The day ended with GERN 4% higher at 1.57, outperforming a weaker sector.

Trading Volume

Above 10d avg 11.4M

11.4M

vs S&P 500 Today

Strong Outperformance

+4.39%

Updated: September 4, 2026 at 20:08 UTC

Technical Indicators

5 Buy3 Neutral0 Sell
GERN presents a buy tilt as the stock trades around 1.57 and rests above its short-, medium- and long-term moving averages, signaling broad upside positioning across timeframes. Momentum readings are mildly positive and RSI is slightly above neutral, while MACD is essentially flat; trend strength remains modest with ADX in the low teens. Volatility is notable relative to price but average true range is small in absolute terms, and on-balance volume shows supportive accumulation despite the modest trend metrics. Technical takeaway: Buy — price sitting above most moving averages supports a constructive stance despite limited trend strength.
All signals
  • EMA (5 indicators)$1.42 - $1.53
    Buy
  • RSI (14)55.32
    Neutral
  • Stochastic %K (14, 3, 3)64.81
    Neutral
  • MACD Level (12, 26)0.02
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.